tert-Butyl 2-(((2-chloro-6-methylpyrimidin-4-yl)amino)methyl)pyrrolidine-1-carboxylate

Catalog No. :
ACSVFA807
CAS No. :
1261231-13-3
Molecular Formula :
C15H23ClN4O2
Molecular Weight :
326.83

IUPAC Name:tert-butyl 2-(((2-chloro-6-methylpyrimidin-4-yl)amino)methyl)pyrrolidine-1-carboxylate

tert-Butyl 2-(((2-chloro-6-methylpyrimidin-4-yl)amino)methyl)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$599.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 2-(((2-chloro-6-methylpyrimidin-4-yl)amino)methyl)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl 2-(((2-chloro-6-methylpyrimidin-4-yl)amino)methyl)pyrrolidine-1-carboxylate
MDL No.MFCD18380175
Molecular FormulaC15H23ClN4O2
Molecular Weight326.83
SMILESO=C(N1C(CNC2=NC(Cl)=NC(C)=C2)CCC1)OC(C)(C)C
InChI KeyFECOJYULZAUOJM-UHFFFAOYSA-N
Synonym2-[(2-Chloro-6-methyl-pyrimidin-4-ylamino)-methyl]-pyrrolidine-1-carboxylic acid tert-butyl ester
CAS No.1261231-13-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSVFA807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXZGB834 route compound structure diagram
    ACXZGB834177911-87-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSVFA807 route product structure diagram
    ACSVFA8071261231-13-3
Inquiry

2. ACSVFA807 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSVFA807 route product structure diagram
    ACSVFA8071261231-13-3
Inquiry

Comments (0)